- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Lapatinib /- Trastuzumab and MM-111
Total 5268 results
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingA Trial of Eribulin in Combination With HP Neoadjuvant Therapy in Patients With for HER2-Positive BCHER2-positive Breast CancerChina
-
Vector OncologyEisai Inc.TerminatedHER-2 Positive Breast CancerUnited States
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Completed
-
Guangdong Provincial People's HospitalRecruitingNeoadjuvant Therapies for HER2+ Breast CancerChina
-
Zhe Jiang Hisun Bioray Bio-pharmaceu tical Co.LtdUnknown
-
Genentech, Inc.Completed
-
Jenny C. Chang, MDGenentech, Inc.; The Methodist Hospital Research InstituteWithdrawnBreast CancerUnited States
-
Cancer Institute and Hospital, Chinese Academy...Unknown
-
Beijing HospitalJiangsu HengRui Medicine Co., Ltd.UnknownHER-2 Negatived Gastric CancerChina
-
Gilead SciencesTerminatedLymphoma, Non-Hodgkin | Chronic Lymphocytic LeukemiaUnited States
-
Beijing Chest HospitalNot yet recruiting
-
Henan Cancer HospitalRecruitingCamrelizumab Plus Apatinib as Maintenance Therapy in Extensive-stage Small-cell Lung Cancer (CAMERA)Small Cell Lung CarcinomaChina
-
Sun Yat-sen UniversityRecruitingNeoadjuvant Therapy | Apatinib | Carilizumab | Recurrent High-Grade GliomaChina
-
Jiangsu HengRui Medicine Co., Ltd.Recruiting
-
Peking University People's HospitalJiangsu HengRui Medicine Co., Ltd.CompletedToxicity | Effect of Drug | DrugChina
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruiting
-
Henan Cancer HospitalJiangsu HengRui Medicine Co., Ltd.Unknown
-
Shanghai Zhongshan HospitalUnknownGastric Cancer | Chemotherapy Effect | Chemotherapeutic ToxicityChina
-
Henan Cancer HospitalJiangsu HengRui Medicine Co., Ltd.Unknown
-
The Affiliated Hospital of the Chinese Academy...Unknown
-
Spanish Breast Cancer Research GroupBristol-Myers SquibbCompletedMetastatic Breast CancerSpain
-
Milton S. Hershey Medical CenterTerminatedChronic Myeloid Leukemia, Chronic PhaseUnited States
-
The Netherlands Cancer InstituteAstraZeneca; Daiichi SankyoRecruiting
-
Fudan UniversityRecruitingEffect of Drug | Gastrointestinal TumorChina
-
AstraZenecaHospital Israelita Albert EinsteinActive, not recruiting
-
Daiichi SankyoAstraZenecaActive, not recruitingNon-Small Cell Lung CancerUnited States, Spain, Korea, Republic of, Italy, France, Japan, Taiwan, Netherlands, Australia, Canada
-
Memorial Sloan Kettering Cancer CenterUnited States Department of Defense; Genentech, Inc.CompletedBreast Cancer Metastases | HER2 Positive BreastUnited States
-
Centre Oscar LambretTerminatedBreast Cancer | Metastasis | Sur-expressing Her2-neuFrance
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI); Oregon Health and Science UniversityTerminatedAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Chronic Myelomonocytic Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Recurrent Acute Lymphoblastic Leukemia | Refractory Acute Lymphoblastic LeukemiaUnited States
-
Frederick R. Ueland, M.D.National Cancer Institute (NCI)Active, not recruiting
-
National Cancer Institute (NCI)CompletedAdvanced Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Recurrent Extrahepatic Bile Duct Cancer | Recurrent Gallbladder Cancer | Unresectable Extrahepatic Bile Duct Cancer | Unresectable Gallbladder Cancer | Adult Primary Hepatocellular...United States
-
University of Michigan Rogel Cancer CenterGlaxoSmithKlineWithdrawnBladder Cancer | Urothelial CancerUnited States
-
Fundacio Clinic BarcelonaRoche Pharma AG; SOLTI Breast Cancer Research GroupRecruitingStage I Breast Cancer | HER2-positive Breast CancerSpain
-
Global Isotopes, LLC d/b/a Zevacor MolecularCompletedMetastatic Prostate CancerUnited States
-
Hebei Medical University Fourth HospitalOrigiMedRecruitingProspective | ObservationalChina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityJiangsu Hengrui Pharmaceutical Co., Ltd.RecruitingHepatocellular CarcinomaChina
-
Zhejiang UniversityRecruitingHepatocellular CarcinomaChina
-
Sun Yat-sen UniversityActive, not recruitingNasopharyngeal Carcinoma | Chemotherapy Effect | Immunotherapy | Recurrent Nasopharyngeal Carcinoma | Metastatic Nasopharyngeal Carcinoma | Molecular Targeted TherapyChina
-
Jiangsu HengRui Medicine Co., Ltd.CompletedHepatocellular CarcinomaChina
-
Hubei Cancer HospitalEnrolling by invitation
-
Peking University Cancer Hospital & InstitutePeking University First Hospital; Shanxi Province Cancer Hospital; Peking University... and other collaboratorsCompleted
-
Peking Union Medical College HospitalJiangsu HengRui Medicine Co., Ltd.CompletedIntrahepatic Cholangiocarcinoma | Second-line TreatmentChina
-
Qianfoshan HospitalJiangsu Hengrui Pharmaceutical Co., Ltd.UnknownImmune Checkpoint InhibitionChina
-
GUO WEICompletedOsteosarcoma | MetastasisChina
-
Tianjin Medical University Cancer Institute and...Zhejiang Cancer Hospital; Fudan University; Liaoning Tumor Hospital & Institute; Gansu Cancer HospitalUnknownSoft Tissue Sarcoma, Adult, Stage IIChina
-
Gilead SciencesCompletedFollicular Lymphoma | Marginal Zone Lymphoma | Small Lymphocytic Lymphoma | Indolent Non-Hodgkin's LymphomaUnited States
-
Ruijin HospitalRecruiting
-
Sun Yat-sen UniversityCompletedRecurrent Cervical Carcinoma | Metastatic Cervical CancerChina